AkramKhanMD

Pulmonology • Portland, OR

Critical Care Medicine, Pulmonary Vascular Medicine, Sleep Medicine

Associate Professor, Medicine, Oregon Health & Science University School of Medicine

Join to view full profile

Dr. Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khan's full profile

Already have an account?

Office
3181 SW Sam Jackson Park Rd
UHN-67
Portland, OR 97239
Phone+1 503-494-1620

Fax+1 503-494-6670

Summary

www.prismtrials.com

Education & Training

Oregon Health & Science UniversityMasters in Clinical Research, Clinical research, 2009 - 2014
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Sleep Medicine, 2006 - 2007
University of Oklahoma Health Sciences CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2006
SSM Health/Saint Louis University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2001
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 1997 - 2000
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Surgery, 1995 - 1997
Maulana Azad Medical CollegeClass of 1994

Certifications & Licensure

WA State Medical License 2019 - 2026
OR State Medical License 2008 - 2025
FL State Medical License 2007 - 2009
IL State Medical License 2001 - 2008
MN State Medical License 2006 - 2008
OK State Medical License 2002 - 2007
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Sleep Quality and Presence of Sleep Disordered Breathing Start of enrollment: 2008 Jun 01
Completed
Predicting Hypotension During Dialysis in the ICU Start of enrollment: 2010 Jul 19
Withdrawn
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis Start of enrollment: 2016 Feb 01
Withdrawn
Phase 2
Severe ARDS: Generating Evidence Start of enrollment: 2016 Oct 01
Completed
Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 Start of enrollment: 2020 Jun 01
Completed
Phase 2
A Study of Baricitinib (LY3009104) in Participants With COVID-19 Start of enrollment: 2020 Jun 12
Completed
Phase 3
GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection Start of enrollment: 2021 Mar 15
Recruiting
Not Applicable
Ventilation Imbalances in Mild to Moderate Chronic Obstructive Pulmonary Disease Start of enrollment: 2021 Jun 30
Enrolling by invitation
Nutrition and Exercise in Critical Illness Start of enrollment: 2017 Sep 28
Recruiting
Phase 2
Roles: Contact
Study of Treatment's Echocardiographic Mechanisms Start of enrollment: 2019 Apr 30
Unknown status
Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Completed
Phase 2, Phase 3
Roles: Contact
ADAPT - A Patient Registry of the Real-world Use of Orenitram® Start of enrollment: 2017 Jul 18
Active, not recruiting
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome Start of enrollment: 2019 Nov 26
Completed
Phase 2
Pragmatic Trial Examining Oxygenation Prior to Intubation Start of enrollment: 2022 Mar 10
Completed
Not Applicable
Roles: Contact
Trial of Therapeutic Hypothermia in Patients With ARDS Start of enrollment: 2021 Jun 29
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, Caitlin C Ten Lohuis, Nathan D Nielsen
Journal of Critical Care. 2025-02-01
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials.
Stephanie C DeMasi, Wesley H Self, Neil R Aggarawal, Michael D April, Luke Andrea
Annals of Emergency Medicine. 2025-01-01
Early Therapeutic Plasma Exchange in Pediatric Transverse Myelitis: A Case Report and Scoping Review.
Akram Khan, José Peña, Genesis Briceño, Juliann M Gronquist, Khurram Khan
Neurology International. 2024-12-04

Press Mentions

Late-Stage Neuromuscular Disorders: MAiDMay 23rd, 2023
Guidelines Developed for Respiratory Management of Neuromuscular DiseaseMarch 17th, 2023
CHEST Unveils Guideline for Respiratory Management of Neuromuscular DiseasesMarch 16th, 2023
Join now to see all